GT Biopharma (GTBP) Market Capitalization (2018 - 2026)
GT Biopharma's Market Capitalization came in at $576,983 for Q1 2026, up 164.5% from $218,130 a year earlier and up 231.2% from the prior quarter.
Powered by 
Analysis
GT Biopharma (GTBP) Market Capitalization (2018 - 2026) Analysis & Trends
For FY2025, GT Biopharma's Market Capitalization was $174,219, down 36.1% from FY2024.
- Market Capitalization has declined in each of the last four years, with a five-year compound annual growth rate of -35.0% (FY2020 to FY2025).
- Going back by year, Market Capitalization was $272,588 in FY2024 (-35.5%), $422,471 in FY2023 (-63.6%), $1.16 million in FY2022 (-70.4%) and $3.91 million in FY2021 (+160.0%).
- The Q1 2026 figure represents the highest quarterly Market Capitalization since Q1 2023.
- Year-over-year, Market Capitalization increased in two of the last eight quarters, with growth averaging 7.4%.
- The fastest year-over-year change in Market Capitalization over five years came in Q1 2026 (growth of 164.5%), and the weakest in Q2 2023 (a decline of 86.2%).
- Business Quant data shows GTBP's Market Capitalization at $174,219 (Q4 2025), $93,001 (Q3 2025) and $468,694 (Q2 2025) in the three quarters before Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | GT Biopharma | 9.11 Mn | 9.11 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 576,983.15 |
| Dec 31, 2025 | 174,218.70 |
| Sep 30, 2025 | 93,001.11 |
| Jun 30, 2025 | 468,693.59 |
| Mar 31, 2025 | 218,130.41 |
| Dec 31, 2024 | 272,587.65 |
| Sep 30, 2024 | 206,451.62 |
| Jun 30, 2024 | 193,792.73 |
| Mar 31, 2024 | 244,646.74 |
| Dec 31, 2023 | 422,471.26 |
| Sep 30, 2023 | 399,240.60 |
| Jun 30, 2023 | 507,134.14 |
| Mar 31, 2023 | 811,338.00 |
| Dec 31, 2022 | 1.16 Mn |
| Sep 30, 2022 | 2.29 Mn |
| Jun 30, 2022 | 3.67 Mn |
| Mar 31, 2022 | 3.73 Mn |
| Dec 31, 2021 | 3.91 Mn |
| Sep 30, 2021 | 8.22 Mn |
| Jun 30, 2021 | 17.45 Mn |
API Access
GT Biopharma Market Capitalization API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=market-capitalization&ticker=GTBP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "market-capitalization", "ticker": "GTBP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=market-capitalization&ticker=GTBP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();